Background In many resource‐constrained countries, control of blood pressure (BP) is low.
Antihypertensive drug prescribing practices may influence BP control. However, adherence …

Systemic hypertension (HTN) is the most prevalent non-communicable disease and the
leading cause for major cardiovascular events, renal failure and cognitive decline. The …

Elevated blood pressure remains a major cause of cardiovascular disease, disability, and
premature death in Austria, with suboptimal rates of detection, treatment and control also in …

Abstract The Systolic Blood Pressure Intervention Trial (SPRINT) compared the clinical
outcomes between target systolic blood pressure (SBP) levels between 140 and 120 mmHg …

A fixed combination of Nivolumab and Relatlimab (OPDUALAG) are human monoclonal
antibodies (mAb) that are extensively used to treat skin cancer melanoma. The current …

Steady increase in worldwide prevalence of hypertension and hypertension-related
cardiovascular morbidity and mortality necessitate new approaches to the management of …

As frequent changes in anti-hypertensive (HTN) medications may reduce adherence to the
treatments, identifying modifiable factors leading to changes in anti-HTN medications can …

Sažetak Hypertension is the leading cause of cardiovascular (CV) morbidity and mortality
worldwide. In spite of many different recommendations and actions related to screening and …

Sažetak In spite of optimization and simplification of arterial hypertension (AH) treatment,
achieving blood pressure (BP) control is still challenging, with most patients requiring …

SABIO, Rodrigo et al. Latin American recommendations for the management of hypertension
in adults (RELAHTA 2). Rev. virtual Soc. Parag. Med. Int.[online]. 2019, vol. 6, n. 1, pp. 86 …